Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

Elanco gets EU’s conditional antitrust OK for Bayer deal

Approval calls for sale of Vecoxan brand, among others

Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more

(Leonid Eremeychuk/iStock/Getty Images)

Court blocks sales of dicamba in U.S.

Bayer says it's seeking new EPA registration for 2021

Updated — Reuters — A U.S. appeals court has blocked Bayer from selling an agricultural weed killer in the United States, the latest setback for a business already fighting an expensive legal battle over another product. A three-judge panel of the Ninth U.S. Circuit Court of Appeals ruled the U.S. Environmental Protection Agency (EPA) substantially […] Read more


(Dave Bedard photo)

Bayer reporting progress in Roundup settlement talks

Frankfurt | Reuters — Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup herbicide causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases. The drugs and pesticides group is keen to draw a line under the legal dispute, which it […] Read more

Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

Proxy advisers split over endorsing Bayer management

Chemical giant to host AGM April 28

Frankfurt | Reuters — Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer, according to recommendations submitted by proxy voting firms. Bayer is due to host its annual general meeting on April 28 but the company still faces potentially huge litigation risks stemming from […] Read more


(Dave Bedard photo)

Bayer reported inching toward glyphosate settlement

Reuters — Bayer has agreed on draft settlement terms with half a dozen law firms representing tens of thousands of plaintiffs alleging that its Roundup herbicide causes cancer, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of the German drugs and pesticides company have come under immense pressure since […] Read more

A new mode of action coming from Bayer

A new mode of action coming from Bayer

New MOA may help farmers fight herbicide resistance

In a February 13 conference call, Bayer management told ag media about the company’s extensive research and development pipeline. Short-stature corn is in the works — that is, corn plants with shorter stalks, meaning decreased lodging problems and fewer nutrients needed. But for most Prairie farmers, Bayer’s upcoming new herbicide with a brand new mode […] Read more


(ImagineGolf/E+/Getty Images)

Ag chem industry watching COVID-19’s spread

MarketsFarm –– China is a major producer of agricultural chemicals — and disruptions to production would have a ripple effect on North American supplies of crop protection inputs, such as herbicides and insecticides. Plant closures and transportation issues due to the spread of COVID-19 coronavirus are being followed closely, but the Canadian industry is reportedly […] Read more




(Jack Dykinga photo courtesy ARS/USDA)

Industry leaders weigh in on seed royalty review

'Other markets... have already moved past this'

Syngenta’s Trevor Heck isn’t choosing a route for collecting seed royalty rates — but says the federal government needs to “move forward on some type of value capture” model. “Right now, you know, if we don’t have that within the seed industry, it’s going to be very difficult to be able to get the level […] Read more